key: cord-0842589-fmv9zy93
authors: Tunc, E. M.; Koid Jia Shin, C.; Usoro, E.; Thomas-Smith, S. E.; Migita, R. T.; Trehan, I.; Keilman, A. E.
title: Pediatric Croup during the COVID-19 Omicron Variant Surge
date: 2022-02-04
journal: nan
DOI: 10.1101/2022.02.02.22270222
sha: 99c8797c15f9ccfc06c568c67e443335cc9e5e5d
doc_id: 842589
cord_uid: fmv9zy93

Croup is a common upper respiratory disease usually associated with parainfluenza virus, resulting in stridor, hoarse voice, barky cough, and variable respiratory distress. Here we examine the data at our center confirming a sharp increase in cases of croup associated with the Omicron variant. Data was retrospectively extracted from patient charts among those seen in the Emergency Department at Seattle Children's Hospital. Inclusion criteria were patients who were assigned a diagnosis containing "croup" during either 5/30/2021-11/30/2021, a time period correlating with predominance of the COVID-19 Delta variant (B.1.617.2), or the initial phase of the Omicron variant surge (12/1/2021-1/15/2022). Contemporaneous publicly available local data on the proportion of SARS-CoV-2 samples in surrounding King County, Washington, with spike gene target failure on TaqPath PCR assays was used as a proxy for the proportion of infections caused by the Omicron variant. A total of 401 patients were diagnosed with croup during the Delta surge and 107 patients were diagnosed with croup during the Omicron surge. Patients who presented during the Omicron surge were more likely to test positive for COVID-19 (48.2% vs 2.8%, p < 0.0001). Children with a clinical diagnosis of croup during the Omicron surge were more likely to be prescribed racemic epinephrine as part of their care (21.5% vs 13.0%, p = 0.032). There were no differences in presenting age, rate of admission, rate of return to the ED within 72 hours, or admission among those who returned within 72 hours. During the Omicron surge, the incidence of croup nearly doubled compared to the rate in prior months, while at the same time the number of cases of parainfluenza virus identified decreased. Consistent with prior case reports, we have identified a sharp rise in cases of croup seen in our pediatric ED in parallel with the replacement of the SARS-CoV-2 Delta variant by Omicron as the dominant variant in our community.

Croup is a common upper respiratory disease usually associated with parainfluenza virus, resulting in stridor, hoarse voice, barky cough, and variable respiratory distress. Here we examine the data at our center confirming a sharp increase in cases of croup associated with the Omicron variant. Data was retrospectively extracted from patient charts among those seen in the Emergency Department at Seattle Children's Hospital. Inclusion criteria were patients who were assigned a diagnosis containing "croup" during either 5 Patients who presented during the Omicron surge were more likely to test positive for COVID-19 (48.2% vs 2.8%, p < 0.0001). Children with a clinical diagnosis of croup during the Omicron surge were more likely to be prescribed racemic epinephrine as part of their care (21.5% vs 13.0%, p = 0.032). There were no differences in presenting age, rate of admission, rate of return to the ED within 72 hours, or admission among those who returned within 72 hours. During the Omicron surge, the incidence of croup nearly doubled compared to the rate in prior months, while at the same time the number of cases of parainfluenza virus identified decreased.

Consistent with prior case reports, we have identified a sharp rise in cases of croup seen in our pediatric ED in parallel with the replacement of the SARS-CoV-2 Delta variant by Omicron as the dominant variant in our community.

Croup (viral laryngotracheitis) is a common upper respiratory disease usually associated with parainfluenza virus, resulting in stridor, hoarse voice, barky cough, and variable respiratory distress. 1 Sporadic case reports have suggested an association between SARS-CoV-2 and croup. [2] [3] [4] [5] Early ex vivo studies suggest that the Omicron variant (B.1.1.529) of SARS-CoV-2 replicates more rapidly in higher airways than previous lineages. 6 Here we examine the data at our center confirming a sharp increase in cases of croup associated with the Omicron variant.

High-level data was retrospectively extracted from patient charts among those seen in the Emergency Department (ED) at Seattle Children's Hospital (SCH), an academic, quaternarycare, free-standing children's hospital with more than 50,000 annual ED visits prior to the COVID-19 pandemic. Inclusion criteria were patients who were assigned a diagnosis containing (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. During the Omicron surge, we have seen that the incidence of croup nearly doubled compared to the rate in prior months, while at the same time the number of cases of parainfluenza virus identified decreased (Figure) .

Consistent with prior case reports, we have identified a sharp rise in cases of croup seen in our pediatric ED in parallel with the replacement of the SARS-CoV-2 Delta variant by Omicron as the dominant variant in our community. This increase is not temporally associated with the circulation of parainfluenza virus, and indeed Omicron has replaced parainfluenza as the predominant cause of viral croup at this time. Viral testing is not routinely recommended for All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted February 4, 2022. ; https://doi.org/10.1101/2022.02.02.22270222 doi: medRxiv preprint patients with croup; testing that was performed was for a wide variety of patients and indications, but we do believe our data is a reasonable proxy for local population prevalence. The end of the study period coincides with a change in our hospital practice due to test supply limitations and thus we are not able to see if this current trend continues with as much precision.

Children with croup during this time were more likely to receive racemic epinephrine, perhaps suggesting a more severe initial clinical presentation, but since treatment was up to individual clinician judgment and thus no definitive statements can be made in this regard. Based on admission rates and return visits, there is no data to support changing the current standard of care for individual patient management. 

SARS-CoV-2 and croup, a rare relationship or coincidence?

COVID-19 Pandemic Impact on Respiratory Infectious Diseases in Primary Care Practice in Children

SARS-CoV-2 and croup, not a rare coincidence

Pediatric croup with COVID-19

SARS-CoV-2 Omicron variant replication in human respiratory tract ex vivo. Nature Portfolio. 2022. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder